Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Altimmune, Inc. (ALT)

3.0200 +0.2000 (+7.09%)
At close: May 4 at 4:00:01 PM EDT
3.0000 -0.0200 (-0.66%)
Pre-Market: 5:38:28 AM EDT
Trade ALT on Coinbase
Chart Range Bar
Loading chart for ALT

News headlines Altimmune recently raised $225 millionthrough an oversubscribed public offering to fund its Phase 3 trial for pemvidutide, targeting metabolic dysfunction-associated steatohepatitis (MASH). Analysts highlight the potential for 315% upsidebased on pemvidutide's revenue projections, with significant upcoming clinical milestones in 2026.

Altimmune recently raised $225 millionthrough an oversubscribed public offering to fund its Phase 3 trial for pemvidutide, targeting metabolic dysfunction-associated steatohepatitis (MASH). Analysts highlight the potential for 315% upsidebased on pemvidutide's revenue projections, with significant upcoming clinical milestones in 2026.

Updated 1h ago · Powered by Yahoo Scout
  • Previous Close 2.8200
  • Open 2.8450
  • Bid 2.9400 x 5300
  • Ask 3.0500 x 5300
  • Day's Range 2.8400 - 3.0400
  • 52 Week Range 2.5600 - 7.7300
  • Volume 5,149,967
  • Avg. Volume 3,988,501
  • Market Cap (intraday) 586.953M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0000
  • Earnings Date (est.) May 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jan 20, 2017
  • 1y Target Est 18.15

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

altimmune.com

57

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview: ALT

Trailing total returns as of 5/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALT
16.34%
S&P 500 (^GSPC)
5.19%

1-Year Return

ALT
47.66%
S&P 500 (^GSPC)
26.63%

3-Year Return

ALT
38.87%
S&P 500 (^GSPC)
77.31%

5-Year Return

ALT
78.07%
S&P 500 (^GSPC)
72.90%

Earnings Trends: ALT

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 26k
Earnings -27.36M

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-25M
-20M
-15M
-10M
-5M
0

Analyst Insights: ALT

View More

Analyst Price Targets

2.50
18.15 Average
3.0200 Current
28.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/16/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 12 -> 25

Statistics: ALT

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    548.08M

  • Enterprise Value

    310.31M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.06k

  • Price/Book (mrq)

    2.44

  • Enterprise Value/Revenue

    7.57k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -28.17%

  • Return on Equity (ttm)

    -50.57%

  • Revenue (ttm)

    41k

  • Net Income Avi to Common (ttm)

    -88.09M

  • Diluted EPS (ttm)

    -1.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    273.46M

  • Total Debt/Equity (mrq)

    15.87%

  • Levered Free Cash Flow (ttm)

    -38.72M

Compare To: ALT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: ALT

Fair Value

3.0200 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: ALT

View More
  • Daily – Vickers Top Insider Picks for 04/08/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 04/07/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 04/03/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 04/02/2026

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: